Login / Signup

Comparing narrative storytelling ability in individuals with autism and fetal alcohol spectrum disorders.

Linh N H PhamAdrian Kc LeeAnnette EstesStephen DagerSusan J Astley HemingwayJohn C ThorneBonnie K Lau
Published in: International journal of language & communication disorders (2023)
What is already known on the subject Narrative discourse, or storytelling, is used in daily conversational interactions and reveals higher-level language skills that may not be well captured by standardised assessments of language. Many autistic individuals and individuals with fetal alcohol spectrum disorders (FASD) show difficulty with pragmatic and expressive language skills. What this paper adds to existing knowledge We found that many aspects of the narratives produced by the adolescents/young adults in the autism and FASD groups were comparable to each other and to the neurotypical group. However, the groups differed on three global measures of narrative production: rate of speech, number of mazes per total words and the description of conflict/resolution in the narratives produced. Also, significant variability was observed within groups, suggesting that narrative abilities should be considered at an individual level as opposed to their clinical groups. What are the potential or actual clinical implications of this work? This study showed that narrative discourse is an appropriate task that can be added to routine clinical assessments of language abilities in autistic adolescents/young adults as well as those with FASD or typical development and has the potential to reveal higher-level, real-world language skills. An important clinical implication of this study is that narrative language abilities should be considered at an individual level and individual-tailored interventions based on ability level due to the variability observed across individuals.
Keyphrases
  • young adults
  • autism spectrum disorder
  • physical activity
  • intellectual disability
  • gene expression
  • medical students
  • childhood cancer
  • genome wide